Comment to: Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis
Medical Ultrasonography · 2024
DOI: 10.11152/mu-4429 ↗Kurz gefasst
Leserbrief in der Zeitschrift Medical Ultrasonography, 2024. Verfasst von Ke Xu. Beteiligte Einrichtung: Ultrasound Department, The Second Affiliated Hospital of Chengdu Medical College, Chengdu, China. xuke808080@163.com. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Contrast Media, Liver Neoplasms, Ultrasonography.
Abstract (Originalsprache)
.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ultrasound Department, The Second Affiliated Hospital of Chengdu Medical College, Chengdu, China. xuke808080@163.com.
Zitieren
APA
Xu, K. (2024). Comment to: Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis. Medical Ultrasonography. https://doi.org/10.11152/mu-4429
Vancouver
Xu K. Comment to: Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis. Medical Ultrasonography. 2024. doi:10.11152/mu-4429
BibTeX
@article{Xu2024,
author = {Xu, Ke},
title = {Comment to: Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis},
journal = {Medical Ultrasonography},
year = {2024},
doi = {10.11152/mu-4429}
}
EUVIMED